Clinical Trial Update: Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating Bictegravir/Lenacapavir in children and adolescents with HIV-1 is active/not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bictegravir/Lenacapavir (bictegravir/lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING